TY -的盟Alaslawi Hessah盟——Berrou Ilhem AU -艾尔·哈米德,阿卜杜拉盟——Alhuwail达里语盟——Aslanpour佐伊PY - 2022 DA - 2022/7/28 TI -糖尿病自我管理的应用:系统回顾采用的决定因素和未来研究议程乔- JMIR糖尿病SP - e28153六世- 7 - 3 KW -糖尿病自我管理KW -移动应用KW -移动健康KW - mHealth采用KW -手机AB -背景:大多数糖尿病管理涉及到自我管理。有效的自我管理可以改善糖尿病的控制，降低并发症的风险，并改善患者的预后。糖尿病自我管理(DSM)手机应用程序可以增强患者的自我管理活动。然而，只有当临床医生推荐它们，患者使用它们时，它们才有效。目的:本研究旨在探讨患者使用DSM应用程序的决定因素以及卫生保健专业人员(HCPs)对其的建议。它还概述了在糖尿病护理中使用DSM应用程序的未来研究议程。方法:我们系统地回顾了影响患者和hcp采用DSM应用程序的因素。使用PubMed、Scopus、CINAHL、Cochrane Central、ACM和Xplore数字图书馆搜索2008年至2020年发表的文章。搜索词是糖尿病、移动应用程序和自我管理。从纳入的研究中提取相关数据，并使用主题综合方法进行分析。 Results: A total of 28 studies met the inclusion criteria. We identified a range of determinants related to patients’ and HCPs’ characteristics, experiences, and preferences. Young female patients were more likely to adopt DSM apps. Patients’ perceptions of the benefits of apps, ease of use, and recommendations by patients and other HCPs strongly affect their intention to use DSM apps. HCPs are less likely to recommend these apps if they do not perceive their benefits and may not recommend their use if they are unaware of their existence or credibility. Young and technology-savvy HCPs were more likely to recommend DSM apps. Conclusions: Despite the potential of DSM apps to improve patients’ self-care activities and diabetes outcomes, HCPs and patients remain hesitant to use them. However, the COVID-19 pandemic may hasten the integration of technology into diabetes care. The use of DSM apps may become a part of the new normal. SN - 2371-4379 UR - https://diabetes.www.mybigtv.com/2022/3/e28153 UR - https://doi.org/10.2196/28153 UR - http://www.ncbi.nlm.nih.gov/pubmed/35900826 DO - 10.2196/28153 ID - info:doi/10.2196/28153 ER -